Moclobemide and fluoxetine in atypical depression: a double-blind trial
Jouko Lönnqvist, Olli Kiviruusu(Finnish Institute for Health and Welfare), Sinikka Sihvo(National Centre for Research and Development), Erkka Syvälahti(University of Turku)
Cited by 81
Related Papers
Large recurrent microdeletions associated with schizophrenia
|Nature|2008|1.8k
Common variants conferring risk of schizophrenia
|Nature|2009|1.7k
Disruption of the neurexin 1 gene is associated with schizophrenia
|Human Molecular Genetics|2008|485
Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders
|Nature Neuroscience|2016|476